Table 1. Demographic, clinical, and treatment characteristics of patients diagnosed with prostate cancer between 2002–2003 in SUS, Brazil.
| Characteristics studied | n | % |
|---|---|---|
| Total | 16,280 | 100 |
| Age group at the start of the follow-up (years) | ||
| 20–59 | 1,739 | 10.7 |
| 60–69 | 5,121 | 31.5 |
| 70–79 | 7,148 | 43.9 |
| ≥ 80 | 2,272 | 14.0 |
| Region of residence | ||
| Southeast | 8,711 | 53.5 |
| South | 2,677 | 16.4 |
| Midwest | 763 | 4.7 |
| North | 439 | 2.7 |
| Northeast | 3,690 | 22.7 |
| Clinical stages | ||
| Stage I | 1,194 | 7.3 |
| Stage II | 5,705 | 35.1 |
| Stage III | 4,149 | 25.5 |
| Stage IV | 5,232 | 32.1 |
| First outpatient treatment | ||
| Radiotherapy | 6,175 | 37.9 |
| Hormone therapy – First line | 7,298 | 44.8 |
| Hormone therapy – Second line | 2,666 | 16.4 |
| Castration-resistant chemotherapy | 141 | 0.9 |
| Hospitalized in SUS | ||
| No | 13,124 | 80.6 |
| es | 3,156 | 19.4 |
| Number of hospitalizations | ||
| 0 | 13,124 | 80.6 |
| 1 | 1,919 | 11.8 |
| 2 | 687 | 4.2 |
| 3 | 256 | 1.6 |
| ≥ 4 | 294 | 1.8 |
| Death during the study period | ||
| No | 8,914 | 54.8 |
| Yes, by prostate cancer | 4,037 | 24.8 |
| Yes, by other causes | 3,329 | 20.5 |
Source: Base Onco, 2006.